Literature DB >> 33866458

Associations between ACA-related policies and a clinical recommendation with HPV vaccine initiation.

Summer Sherburne Hawkins1, Krisztina Horvath2, Jessica Cohen3, Lydia E Pace4, Christopher F Baum5,2,6.   

Abstract

PURPOSE: We examined associations between the 2010 Affordable Care Act (ACA) provisions, 2011 Advisory Committee on Immunization Practices (ACIP) recommendation, and 2014 ACA-related health insurance reforms with HPV vaccine initiation rates by sex and health insurance type.
METHODS: Using 2009-2015 public and private health insurance claims for 551,764 males and females aged 9-26 years (referred to as youth) from Maine, New Hampshire, and Massachusetts, we conducted linear regression models to examine the associations between three policy changes and HPV vaccine initiation rates by sex and health insurance type.
RESULTS: In 2009, HPV vaccine initiation rates for males and females were 0.003 and 0.604 per 100 enrollees, respectively. Among males, the 2010 ACA provisions and ACIP recommendation were associated with significant increases in HPV vaccine uptake among those with private plans (0.207 [0.137, 0.278] and 0.419 [0.353, 0.486], respectively) and Medicaid (0.157 [0.083, 0.230] and 0.322 [0.257, 0.386], respectively). Among females, the 2010 ACA provisions were associated with significant increases in HPV vaccine uptake among Medicaid enrollees only (0.123 [0.033, 0.214]). The ACA-related health insurance reforms were associated with significant increases in HPV vaccine uptake for male and female Medicaid enrollees (0.257 [0.137, 0.377] and 0.214 [0.102, 0.327], respectively), but no differences among privately insured youth. By 2015, there were no differences in HPV vaccine initiation rates between males (0.278) and females (0.305).
CONCLUSIONS: Both ACA provisions and the ACIP recommendation were associated with significant increases in HPV vaccine initiation rates among privately and publicly insured males in three New England states, closing the gender gap. In contrast, females and youth with private insurance did not exhibit the same changes in HPV vaccine uptake over the study period.

Keywords:  Affordable care act; Health disparity; Human papillomavirus; Policy; Vaccine

Mesh:

Substances:

Year:  2021        PMID: 33866458     DOI: 10.1007/s10552-021-01430-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

1.  Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007-2016.

Authors:  Rayleen M Lewis; Lauri E Markowitz
Journal:  Vaccine       Date:  2018-04-09       Impact factor: 3.641

2.  Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.

Authors:  Karen A Cullen; Shannon Stokley; Lauri E Markowitz
Journal:  Acad Pediatr       Date:  2014-06-20       Impact factor: 3.107

Review 3.  Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review.

Authors:  Lisa Rambout; Mariam Tashkandi; Laura Hopkins; Andrea C Tricco
Journal:  Prev Med       Date:  2013-10-28       Impact factor: 4.018

4.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

5.  Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Harrell W Chesson; C Robinette Curtis; Julianne Gee; Joseph A Bocchini; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2014-08-29

6.  Trends and Disparities in Sexual and Reproductive Health Behaviors and Service Use Among Young Adult Women (Aged 18-25 Years) in the United States, 2002-2015.

Authors:  Mara E Murray Horwitz; Lydia E Pace; Dennis Ross-Degnan
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

Review 7.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

8.  Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Authors:  Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

Review 9.  Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.

Authors:  Harriet Fisher; Caroline L Trotter; Suzanne Audrey; Kyle MacDonald-Wallis; Matthew Hickman
Journal:  Int J Epidemiol       Date:  2013-04-25       Impact factor: 7.196

Review 10.  Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies.

Authors:  Carmen H Logie; Ashley Lacombe-Duncan; Philip Baiden; Peter A Newman; Suchon Tepjan; Clara Rubincam; Nick Doukas; Farid Asey
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.